Intellihealth Wins Amplifyher Ventures Investment Competition At Weill Cornell Medicine
05/04/21, 12:07 PM
Intellihealth, creator of the first cloud-based clinical decision-making software and population health management platform for the medical treatment of obesity, has won the Women at Weill investment competition and will receive funding from AmplifyHer Ventures, a venture capital fund that invests in early-stage businesses built by outstanding women. The competition results were announced at the recent Weill Cornell Medicine Startup Symposium.
Company Info
Additional Info
Intellihealth offers a clinically proven medical obesity treatment approach that is three times more effective than lifestyle intervention alone. The company’s flagship product, Evolve, enables health care providers to offer effective medical obesity treatment to new and existing patients, both via telehealth and in person. More information and a product demonstration can be found at www.intellihealth.co.